RARA CRAFT DATABASE for FDA Medical Devices
510(k)K260048

FDA DEVICE FACTS

Elecsys Anti-HAV IgM

Roche Diagnostics

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEApril 7, 2026PRODUCT CODELOLCLINICAL AREAClinical Laboratory

Indications for use

Immunoassay for the in vitro qualitative detection of IgM antibodies to hepatitis A virus (anti-HAV IgM) in human serum and plasma (potassium EDTA, lithium heparin, sodium heparin, sodium citrate) from adult and pediatric (2 through 21 years of age) patients with signs and symptoms of hepatitis or persons who may be at risk for hepatitis A infection. The assay is intended for use as an aid in the laboratory diagnosis of an acute or recently acquired hepatitis A virus (HAV) infection. Assay results, in conjunction with other laboratory results and clinical information, may be used to provide presumptive evidence of infection with HAV. The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 16, 2026